Special Issue

Neurodegenerative Diseases: New Drugs for Prevention and Treatment, and Mechanisms of Occurrence

Submission Deadline: 31 Dec 2025

Guest Editors

  • Portrait of Guest Editor Stepan  Dzhimak

    Stepan Dzhimak PhD

    Kuban State University, Krasnodar, Russia

    Interests: comenic acid; magnesium ions; magnesium complex compounds; immobilization stress; antioxidants; neuroprotectors; neuritic growth; excitotoxicity; DNA; mathematical models; entropy; solvent viscosity; rotational movements of nitrogenous bases; dynamics of a double-stranded DNA molecule

    Special Issue in IMR Press journals

  • Portrait of Guest Editor Anna  Dorohova

    Anna Dorohova PhD

    Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia

    Interests: gamma-pyrones; comenic acid; lithium; lithium comenate; lithium complex compounds; neuroprotection; antioxidant; excitotoxicity; DNA dynamics; open states; torque; mathematical model

    Special Issue in IMR Press journals

Special Issue Information

Dear Colleagues,

This special issue entitled “Neurodegenerative diseases: New drugs for prevention and treatment, and mechanisms of occurrence,” will publish original scientific articles, short communications, and review articles that present the latest advances in the development of drugs with neuroprotective properties; in addition, the mechanisms of disease occurrence will be considered. Neurodegeneration is the primary pathophysiological change in most diseases of the central nervous system. On this topic, the most relevant areas of research are the development of new drugs for the prevention and treatment of neurodegenerative diseases, as well as genetic studies to determine the mechanisms underlying their occurrence. The new special issue of Frontiers in Bioscience – Landmark will be dedicated to the search for new biochemical pathways through which disease correction can be carried out, as well as genetic mechanisms involved in disorders such as trinucleotide repeat diseases (spinocerebral ataxia and others), Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis.

Dr. Stepan Dzhimak and Dr. Anna Dorohova
Guest Editors

Keywords

  • neuroprotectors
  • antioxidants
  • spinocerebral ataxia
  • amyotrophic lateral sclerosis

Share